Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RILMENIDINE vs RISANKIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RILMENIDINE vs RISANKIZUMAB: Safety Overview

Metric RILMENIDINE RISANKIZUMAB
Total FAERS Reports 899 2,642
Deaths Reported 103 41
Death Rate 11.5% 1.6%
Hospitalizations 536 439
Average Patient Age 73.4 yrs 52.1 yrs
% Female Patients 65.3% 51.3%
Manufacturer N/A AbbVie Inc.
Route N/A SUBCUTANEOUS